Bain, Stephen C ;
Mosenzon, Ofri ;
Arechavaleta, Rosario...
Bain , S C , Mosenzon , O , Arechavaleta , R , Bogdański , P , Comlekci , A , Consoli , A , Deerochanawong , C , Dungan , K , Faingold , M C , Farkouh , M E , Franco , D R , Gram , J , Guja , C , Joshi , P , Malek , R , Merino-Torres , J F , Nauck , M A , Pedersen , S D , Sheu , W H H , Silver , R J , Tack , C J , Tandon , N , Jeppesen , O K , Strange , M , Thomsen , M & Husain , M 2019 , ' Cardiovascular safety of oral semaglutide in patients with type 2 diabetes : Rationale, design and patient baseline characteristics for the PIONEER 6 trial ' , Diabetes, Obesity and Metabolism , vol. 21 , no. 3 , pp. 499-508 . https://doi.org/10.1111/dom.13553.
,
2019